Web Results

en.wikipedia.org/wiki/Novo_Nordisk

Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in eight countries, and affiliates or offices in 75 countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 25% of its shares and a supermajority ...

www.novonordisk-us.com/whoweare/about-novo-nordisk/novo-nordisk-in-the-US/clayton-nc.html

Voted to Carolina Parenting Inc. Magazine's List of “Top 50 Family Friendly Companies” and Most Valuable Employer for Military® by CivilianJobs.com, the Diabetes Finished Products and Diabetes Active Pharmaceutical Ingredients manufacturing facilities in Clayton, North Carolina will soon employ nearly 1,500 members ...

www.novonordisk-us.com

Latest News. Perspectives: First break home, freshman year 12 Dec 2017. Novo Nordisk receives FDA approval of a new medicine for adults with type 2 diabetes 05 Dec 2017. Read all Press Releases ...

www.novonordisk-us.com/careers.html

If you receive any suspicious calls from someone claiming to be representing Novo Nordisk Inc. asking you to interview via instant messenger or purchase equipment, please contact our compliance hotline immediately at (888)-536- 1504. We thank you for you for your cooperation and apologize for any inconveniences.

www.novonordisk.com

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

press.novonordisk-us.com/2016-03-28-Novo-Nordisk-breaks-ground-on-nearly-2-billion-diabetes-medicine-production-facility-in-Clayton-North-Carolina

Mar 28, 2016 ... The facility will produce active pharmaceutical ingredients (API) for a range of Novo Nordisk's current and future GLP-1 and insulin medicines. ... "Novo Nordisk's billion dollar decision to bring this landmark manufacturing facility to North Carolina underscores its commitment to our state and confidence in ...

directory.ncbiotech.org/content/novo-nordisk-pharmaceutical-industries-lp

Novo Nordisk Pharmaceutical Industries LP. Novo Nordisk's Clayton facility manufactures insulin, GLP-1 products and prefilled delivery devices for the treatment of diabetes. An API facility is presently under construction in Clayton adjacent to the existing manufacturing site. http://www.novonordisk-clayton.com ...

www.newsobserver.com/news/business/article68765952.html

Mar 29, 2016 ... Local, state and federal politicians joined Novo Nordisk executives Monday as the company broke ground on a new $1.8 billion insulin manufacturing facility in Clayton. ... The stretch along U.S. 70 in Clayton where Novo Nordisk is building the new plant has become a center for pharmaceutical production.

www.linkedin.com/company/novo-nordisk

At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Diabetes poses one of today's biggest global health challenges. We work for a future where fewer people get diabetes, everyone with diabetes is diagnosed, and everyone who is diagnosed receives adequate treatment and ...